Literature DB >> 12034685

Reliability of expert interpretation of retinal photographs for the diagnosis of toxoplasma retinochoroiditis.

M R Stanford1, L Gras, A Wade, R E Gilbert.   

Abstract

AIMS: To measure agreement and estimate sensitivity and specificity of uveitis experts' interpretation of retinal photographs for the diagnosis of toxoplasma retinochoroiditis.
METHODS: The authors collated 96 retinal photographs from patients presenting with symptomatic posterior uveitis to ophthalmology clinics within a defined geographical area. Five uveitis experts independently ranked each photograph as definite, probable, possible, or not toxoplasma retinochoroiditis. They measured interobserver agreement based on an intraclass correlation coefficient and estimated sensitivity and specificity for each observer using a maximum likelihood model.
RESULTS: The intraclass correlation coefficient for all five observers was 0.62 (95% CI: 0.54 to 0.69). Estimates of sensitivity and specificity for individual observers ranged from 71% to 96% and 58% to 100% respectively when appearances were dichotomised as definite or probable toxoplasma retinochoroiditis, versus possible or not.
CONCLUSION: Agreement between uveitis experts on the interpretation of retinal photographs was moderate to good, but the estimates of sensitivity and specificity of their interpretation for the diagnosis of toxoplasma retinochoroiditis were highly variable. Assuming that interpretation of photographs is similar to real time ophthalmoscopy, clinicians need to beware that treatment decisions made on the basis of a single assessment will include patients without toxoplasma retinochoroiditis and will miss patients with the disease.

Entities:  

Mesh:

Year:  2002        PMID: 12034685      PMCID: PMC1771161          DOI: 10.1136/bjo.86.6.636

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  14 in total

1.  TOXOPLASMIC RETINOCHOROIDITIS: A DOUBLE BLIND THERAPEUTIC STUDY.

Authors:  T E ACERS
Journal:  Arch Ophthalmol       Date:  1964-01

2.  An unusually high prevalence of ocular toxoplasmosis in southern Brazil.

Authors:  P D Glasner; C Silveira; D Kruszon-Moran; M C Martins; M Burnier Júnior; S Silveira; M E Camargo; R B Nussenblatt; R A Kaslow; R Belfort Júnior
Journal:  Am J Ophthalmol       Date:  1992-08-15       Impact factor: 5.258

3.  Users' guides to the medical literature. III. How to use an article about a diagnostic test. B. What are the results and will they help me in caring for my patients? The Evidence-Based Medicine Working Group.

Authors:  R Jaeschke; G H Guyatt; D L Sackett
Journal:  JAMA       Date:  1994-03-02       Impact factor: 56.272

4.  Endogenous uveitis: an analysis of 1,417 cases.

Authors:  P Pivetti-Pezzi; M Accorinti; M La Cava; R A Colabelli Gisoldi; M A Abdulaziz
Journal:  Ophthalmologica       Date:  1996       Impact factor: 3.250

5.  Incidence of symptomatic toxoplasma eye disease: aetiology and public health implications.

Authors:  R E Gilbert; D T Dunn; S Lightman; P I Murray; C E Pavesio; P D Gormley; J Masters; S P Parker; M R Stanford
Journal:  Epidemiol Infect       Date:  1999-10       Impact factor: 2.451

6.  Measuring the reliability of clinical data: the case for using three observers.

Authors:  S D Walter
Journal:  Rev Epidemiol Sante Publique       Date:  1984       Impact factor: 1.019

7.  Problems of spectrum and bias in evaluating the efficacy of diagnostic tests.

Authors:  D F Ransohoff; A R Feinstein
Journal:  N Engl J Med       Date:  1978-10-26       Impact factor: 91.245

8.  Current practices in the management of ocular toxoplasmosis.

Authors:  R E Engstrom; G N Holland; R B Nussenblatt; D A Jabs
Journal:  Am J Ophthalmol       Date:  1991-05-15       Impact factor: 5.258

9.  Therapy for ocular toxoplasmosis.

Authors:  A Rothova; C Meenken; H J Buitenhuis; C J Brinkman; G S Baarsma; T N Boen-Tan; P T de Jong; N Klaassen-Broekema; C M Schweitzer; Z Timmerman
Journal:  Am J Ophthalmol       Date:  1993-04-15       Impact factor: 5.258

10.  Causes of uveitis in the general practice of ophthalmology. UCLA Community-Based Uveitis Study Group.

Authors:  C A McCannel; G N Holland; C J Helm; P J Cornell; J V Winston; T G Rimmer
Journal:  Am J Ophthalmol       Date:  1996-01       Impact factor: 5.258

View more
  6 in total

1.  The antibody response in experimental ocular toxoplasmosis.

Authors:  Justus G Garweg; Matthias Boehnke
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-12       Impact factor: 3.117

2.  Active ocular toxoplasmosis in Turkish patients: a report on 109 cases.

Authors:  Ilknur Tugal-Tutkun; Isik Corum; Berna Otük; Meri Urgancioglu
Journal:  Int Ophthalmol       Date:  2007-02-21       Impact factor: 2.031

3.  Comparison of enzyme-linked immunosorbent assay, immunoblotting, and PCR for diagnosis of toxoplasmic chorioretinitis.

Authors:  Odile Villard; Denis Filisetti; Florence Roch-Deries; Justus Garweg; Jacques Flament; Ermanno Candolfi
Journal:  J Clin Microbiol       Date:  2003-08       Impact factor: 5.948

4.  Spectral optical coherence tomography findings in patients with ocular toxoplasmosis: A case series study.

Authors:  Feriel Ammar; Ahmed Mahjoub; Nadia Ben Abdesslam; Leila Knani; Mohamed Ghorbel; Hachmi Mahjoub
Journal:  Ann Med Surg (Lond)       Date:  2020-04-24

5.  Biological Diagnosis of Ocular Toxoplasmosis: a Nine-Year Retrospective Observational Study.

Authors:  Valentin Greigert; Alexander W Pfaff; Arnaud Sauer; Denis Filisetti; Ermanno Candolfi; Odile Villard
Journal:  mSphere       Date:  2019-09-25       Impact factor: 4.389

6.  Utility of blood as the clinical specimen for the diagnosis of ocular toxoplasmosis using uracil DNA glycosylase-supplemented loop-mediated isothermal amplification and real-time polymerase chain reaction assays based on REP-529 sequence and B1 gene.

Authors:  Bahman Rahimi Esboei; Shirzad Fallahi; Mohammad Zarei; Bahram Kazemi; Mehdi Mohebali; Saeedeh Shojaee; Parisa Mousavi; Aref Teimouri; Raziyeh Mahmoudzadeh; Mirataollah Salabati; Hossein Keshavarz Valian
Journal:  BMC Infect Dis       Date:  2022-01-25       Impact factor: 3.090

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.